MoodNCT07398521
A Clinical Trial to Evaluate the Effects of a Supplement on Energy and Mood
A study testing Liposomal Magnesium Complex in people with Mood and Stress, run by Cymbiotika, LLC at 1 site in United States.
Trial summary
This study evaluates the effects of a Liposomal Magnesium Complex supplement on energy and mood. The study is a single-arm, virtual trial in which 60 adult participants consume the supplement daily for 14 days and complete self-reported questionnaires at multiple timepoints. Read more about this study
- Who is it for?
- Ages 18 to 60 yearsHealthy volunteers can take part
- What is being tested?
- Liposomal Magnesium Complex
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteUnited States
- Study dates
- 14 Oct 2025to 8 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Be male or female
- Be aged 18-60
- Anyone currently experiencing issues regarding all of the following: Low energy, Difficulty regulating mood
- Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
- Anyone willing to avoid all other dietary supplements or products containing magnesium for the duration of the trial.
- Anyone willing to refrain from taking any products, prescription medications, or supplements that target energy, mood, stress, and sleep during the test period.
- Anyone willing to maintain their current diet, sleep schedule, and activity level for the duration of the study.
- Resides in the United States.
Who cannot join
- Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including cancer and mental health disorders.
- Anyone with a nut allergy or allergies or sensitivities to any of the product ingredients.
- Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
- Anyone who drinks heavily (i.e., 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men).
- History of diagnosed psychiatric or mood disorders.
- History of diagnosed sleep disorders.
Show all 13Show fewer
- History of serious illness in the last three months.
- History of substance abuse.
- History of kidney disease.
- History of hormone or endocrine disorders, including but not limited to hypothyroidism, Hashimoto's thyroiditis, polycystic ovarian syndrome (PCOS), and diabetes.
- Planned surgery during the study period.
- Currently partaking in another research study or will be partaking in any other research study for the next 2 weeks, or at any point during this study's duration.
- Anyone unwilling to follow the study protocol.
Trial locations and contacts
1 site in 1 country.
About this study
This study evaluates the effects of a Liposomal Magnesium Complex supplement on energy and mood. The study is a single-arm, virtual trial in which 60 adult participants consume the supplement daily for 14 days and complete self-reported questionnaires at multiple timepoints.
- Being tested
- Liposomal Magnesium Complex
- Keywords
- Sleep Quality, Magnesium
- Medical subject headings
- Sleep Initiation and Maintenance Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Liposomal Magnesium ComplexDietary supplement
The supplement is taken in the morning with the first meal of the day for 14 consecutive days.
| Study group | Role | What they receive |
|---|---|---|
| Liposomal Magnesium Complex | Experimental | Participants will consume one packet daily by squeezing the contents directly into the mouth. Receives: Dietary Supplement: Liposomal Magnesium Complex |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Energy Levels
Change in self-reported energy levels following daily use of the Liposomal Magnesium Complex supplement, assessed using participant questionnaires.
Measured: Baseline, Day 3, Day 7, Day 10, Day 14
Change in Mood
Change in self-reported mood following daily use of the Liposomal Magnesium Complex supplement, assessed using participant questionnaires.
Measured: Baseline, Day 3, Day 7, Day 10, Day 14
Secondary outcomes (5)
Change in Stress Levels
Participant-reported changes in perceived stress levels assessed via questionnaire.
Measured: Baseline, Day 3, Day 7, Day 10, Day 14
Change in Relaxation and Calmness
Participant-reported changes in feelings of relaxation and calmness assessed via questionnaire.
Measured: Baseline, Day 3, Day 7, Day 10, Day 14
Change in Balanced Mood
Participant perception of mood balance assessed using self-reported questionnaires.
Measured: Baseline, Day 3, Day 7, Day 10, Day 14
Change in Sleep Quality
Participant-reported changes in sleep assessed via questionnaire.
Measured: Baseline, Day 3, Day 7, Day 10, Day 14
Change in Muscle Tension
Participant-reported changes in muscle tension assessed using questionnaires.
Measured: Baseline, Day 3, Day 7, Day 10, Day 14
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Feb 2026
- Study start14 Oct 2025
- Primary completion8 Dec 2025
- Study completion8 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MoodStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cymbiotika, LLC
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Citruslabs
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07398521
- Sponsor's protocol ID
- 20811
- Status last verified
- Feb 2026
- First submitted
- 4 Feb 2026
- Last updated
- 10 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 10 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Clinical Trial to Evaluate the Effects of a Supplement on Energy and Mood
- ClinicalTrials.gov ID
- NCT07398521
- Acronym / sponsor ID
- 20811
- Keywords
- Sleep Quality, Magnesium
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Cymbiotika, LLCIndustry (pharma, biotech, devices)
- Collaborators
- Citruslabs
- Study start
- 14 Oct 2025 (actual)
- Primary completion
- 8 Dec 2025 (actual)
- Study completion
- 8 Dec 2025 (actual)
- First posted
- 10 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study evaluates the effects of a Liposomal Magnesium Complex supplement on energy and mood. The study is a single-arm, virtual trial in which 60 adult participants consume the supplement daily for 14 days and complete self-reported questionnaires at multiple timepoints.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Liposomal Magnesium Complex | Experimental | Dietary Supplement: Liposomal Magnesium ComplexParticipants will consume one packet daily by squeezing the contents directly into the mouth. |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (8 listed)
- Be male or female
- Be aged 18-60
- Anyone currently experiencing issues regarding all of the following: Low energy, Difficulty regulating mood
- Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
- Anyone willing to avoid all other dietary supplements or products containing magnesium for the duration of the trial.
Key exclusion criteria (13 listed)
- Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including cancer and mental health disorders.
- Anyone with a nut allergy or allergies or sensitivities to any of the product ingredients.
- Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
- Anyone who drinks heavily (i.e., 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men).
- History of diagnosed psychiatric or mood disorders.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Liposomal Magnesium ComplexThe supplement is taken in the morning with the first meal of the day for 14 consecutive days. | Dietary supplement | Liposomal Magnesium Complex |
Primary outcome
Change in Energy Levels
Time frame: Baseline, Day 3, Day 7, Day 10, Day 14
Change in self-reported energy levels following daily use of the Liposomal Magnesium Complex supplement, assessed using participant questionnaires.
Change in Mood
Time frame: Baseline, Day 3, Day 7, Day 10, Day 14
Change in self-reported mood following daily use of the Liposomal Magnesium Complex supplement, assessed using participant questionnaires.
5 secondary outcomes
Change in Stress Levels
Time frame: Baseline, Day 3, Day 7, Day 10, Day 14
Change in Relaxation and Calmness
Time frame: Baseline, Day 3, Day 7, Day 10, Day 14
Change in Balanced Mood
Time frame: Baseline, Day 3, Day 7, Day 10, Day 14
Change in Sleep Quality
Time frame: Baseline, Day 3, Day 7, Day 10, Day 14
Change in Muscle Tension
Time frame: Baseline, Day 3, Day 7, Day 10, Day 14
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Feb 2026.
- Individual participant dataSharing planned: No
Related trials for Mood
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
RecruitingPhase 4
Biomarker-Guided Antidepressant Selection
Depression - Major Depressive Disorder, Treatment-resistant Depression (TRD)
Recruiting
Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics
Major Depressive Disorder, Apathy
RecruitingObservational study
Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy
Irritability, Disruptive Mood Dysregulation Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Liposomal Magnesium Complex in people with Mood and Stress, run by Cymbiotika, LLC at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Energy Levels (time frame: Baseline, Day 3, Day 7, Day 10, Day 14). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Feb 2026.